EPI, Canadian Cancer Lab Look for Protein Markers Tied to Breast Cancer Metastasis | GenomeWeb
Expression Pathology and the Alberta Cancer Board’s Tom Baker Cancer Centre plan to identify protein biomarkers that can enable researchers to detect early breast cancer metastasis, the groups said last week.
Under the terms of the deal, EPI will use its tissue proteomics platform to analyze formalin-fixed, paraffin-embedded tissue samples from breast cancer patients treated at the Calgary-based Tom Baker Cancer Centre and identify protein biomarkers for early disease metastasis.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: diatom genetic diversity, microfluidic droplet method for single-cell screening, and more.

Scientific publishers are looking into whether artificial intelligence can help the peer-review process, Wired reports.

Researchers are using gene editing to develop more robust livestock and crops, AFP reports.

Researchers rally near the American Association for the Advancement of Science annual meeting in Boston.